How GlaxoSmithKline Lost Nearly $10B in October Post author:Sam Post published:November 9, 2017 Post category:BioPharma Could GlaxoSmithKline’s industry-leading dividend be at risk? Source: BioSpace You Might Also Like GlaxoSmithKline is Eyeing Pfizer's $15B+ Consumer Biz January 9, 2018 Genentech Shows Off New Mid-Stage DME Data February 11, 2018 McKesson Reports Fiscal 2017 Fourth-Quarter And Full-Year Results May 18, 2017
